SIMPLEX TRADING, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U908. A total of 4 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$77,000
-87.8%
91,600
+362.6%
0.00%
-100.0%
Q2 2022$632,000
+209.8%
19,800
+235.6%
0.00%
Q1 2022$204,000
-67.6%
5,900
-72.6%
0.00%
-100.0%
Q4 2021$629,000
-37.8%
21,500
-20.7%
0.00%0.0%
Q3 2021$1,011,000
+12.8%
27,100
+5.9%
0.00%0.0%
Q2 2021$896,000
-31.3%
25,600
+7900.0%
0.00%
-50.0%
Q1 2021$1,304,000
-60.3%
320
-57.8%
0.00%
-50.0%
Q4 2020$3,282,000
+361.6%
758
+487.6%
0.00%
+300.0%
Q3 2020$711,000
-54.2%
129
-47.6%
0.00%
-50.0%
Q2 2020$1,552,000
+166.7%
246
+115.8%
0.00%
+100.0%
Q1 2020$582,000
-89.0%
114
-82.9%
0.00%
-91.7%
Q4 2019$5,309,000
+102.6%
668
+23.7%
0.01%
+71.4%
Q3 2019$2,620,000
+31.1%
540
+42.1%
0.01%
+40.0%
Q2 2019$1,998,000
+30.2%
380
+31.0%
0.01%
+25.0%
Q1 2019$1,534,000
+40.6%
290
+9.0%
0.00%
+33.3%
Q4 2018$1,091,000
-31.8%
266
-36.8%
0.00%
-40.0%
Q3 2018$1,599,000
-74.0%
421
-69.0%
0.01%
-79.2%
Q2 2018$6,142,000
+2101.4%
1,359
+309.3%
0.02%
+100.0%
Q1 2018$279,000
-33.3%
332
-49.4%
0.01%
-33.3%
Q4 2017$418,000
+359.3%
656
+145.7%
0.02%
+350.0%
Q3 2017$91,000
+93.6%
267
+10.8%
0.00%
+100.0%
Q2 2017$47,000
-88.3%
241
-73.4%
0.00%
-88.2%
Q1 2017$401,000
+19950.0%
905
+455.2%
0.02%
Q4 2016$2,000
-97.0%
163
-26.2%
0.00%
-100.0%
Q3 2016$66,000
+1000.0%
221
+81.1%
0.00%
Q2 2016$6,000122
+1009.1%
0.00%
Q1 2016$0110.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,516$7,322,0000.44%
GROUP ONE TRADING, L.P. 53,100$2,565,0000.03%
SIMPLEX TRADING, LLC 332$279,0000.01%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders